Research paper
Vitamin C for preventing and treating the common cold.
Study answer
What this study found
Routine vitamin C prophylaxis did not reduce common cold incidence in the general community, but it did in people under brief severe physical stress. In general community trials, the pooled risk ratio for developing a cold was 0.97 (95% CI 0.94 to 1.00), whereas five heavy-exercise trials showed a risk ratio of 0.48 (95% CI 0.35 to 0.64). Prophylaxis modestly shortened cold duration, by 8% in adults and 13% in children, and reduced severity. Therapeutic vitamin C started after symptom onset showed no consistent benefit for duration or severity. Reported adverse effects were uncommon and…
- Study & population
- Systematic review and meta-analysis of randomized comparisons of oral vitamin C for prevention or treatment of the common cold.
- Intervention
- Oral vitamin C was evaluated as continuous prophylaxis and, in some trials, as treatment started after cold onset.
- Key limitation
- The evidence was heterogeneous across populations, doses, and outcome definitions, with many older trials and several small studies.
Original abstract
BACKGROUND The role of vitamin C (ascorbic acid) in the prevention and treatment of the common cold has been a subject of controversy for 60 years, but is widely sold and used as both a preventive and therapeutic agent. OBJECTIVES To discover whether…